Clinical perspectives on reperfusion injury in acute myocardial infarction
- PMID: 24766972
- DOI: 10.1016/j.ahj.2014.01.015
Clinical perspectives on reperfusion injury in acute myocardial infarction
Abstract
Prompt reperfusion therapy in acute myocardial infarction enhances clinical outcome. However, reperfusion itself may contribute to myocardial cell death. The current review outlines the multifocal mechanisms of reperfusion injury and focuses on understanding the potential role of each element and its contribution to the injury pattern inflicted upon the myocardium. We evaluate the spectrum of contemporary therapies that have been tested in an attempt to reduce myocardial injury. Finally, we explore promising innovative strategies targeting novel reperfusion injury pathways to protect ischemic myocardium during reperfusion.
Copyright © 2014 Mosby, Inc. All rights reserved.
Similar articles
-
[Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S76-101. Arch Cardiol Mex. 2006. PMID: 17469337 Review. Spanish.
-
[The basis of ischemia-reperfusion and myocardial protection].Ann Fr Anesth Reanim. 2011 May;30 Suppl 1:S2-16. doi: 10.1016/S0750-7658(11)70002-8. Ann Fr Anesth Reanim. 2011. PMID: 21703480 Review. French.
-
The coronary circulation in cardioprotection: more than just one confounder.Cardiovasc Res. 2012 May 1;94(2):237-45. doi: 10.1093/cvr/cvr271. Epub 2011 Oct 16. Cardiovasc Res. 2012. PMID: 22002502 Review.
-
Clinical efforts to reduce myocardial infarct size--the next step.J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):349-53. doi: 10.1177/1074248411407637. J Cardiovasc Pharmacol Ther. 2011. PMID: 21821538 Review.
-
Myocardial ischemia and reperfusion injury.Cardiovasc Pathol. 2005 Jul-Aug;14(4):170-5. doi: 10.1016/j.carpath.2005.03.006. Cardiovasc Pathol. 2005. PMID: 16009313 Review.
Cited by
-
Hydroxytyrosol protects against myocardial ischemia reperfusion injury by inhibiting mitochondrial permeability transition pore opening.Exp Ther Med. 2019 Jan;17(1):671-678. doi: 10.3892/etm.2018.7016. Epub 2018 Nov 27. Exp Ther Med. 2019. PMID: 30651849 Free PMC article.
-
Long non‑coding RNA GAS5 regulates myocardial ischemia‑reperfusion injury through the PI3K/AKT apoptosis pathway by sponging miR‑532‑5p.Int J Mol Med. 2020 Mar;45(3):858-872. doi: 10.3892/ijmm.2020.4471. Epub 2020 Jan 20. Int J Mol Med. 2020. PMID: 31985016 Free PMC article.
-
Intracoronary Thrombolysis in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: an Updated Meta-analysis of Randomized Controlled Trials.Cardiovasc Drugs Ther. 2024 Apr;38(2):335-346. doi: 10.1007/s10557-022-07402-3. Epub 2022 Nov 8. Cardiovasc Drugs Ther. 2024. PMID: 36346537 Review.
-
Treatment with metformin prevents myocardial ischemia-reperfusion injury via STEAP4 signaling pathway.Anatol J Cardiol. 2019 Apr;21(5):261-271. doi: 10.14744/AnatolJCardiol.2019.11456. Anatol J Cardiol. 2019. PMID: 31062756 Free PMC article.
-
MicroRNA-590-3p relieves hypoxia/reoxygenation induced cardiomyocytes apoptosis and autophagy by targeting HIF-1α.Exp Ther Med. 2021 Oct;22(4):1077. doi: 10.3892/etm.2021.10511. Epub 2021 Jul 28. Exp Ther Med. 2021. PMID: 34447470 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical